Literature DB >> 7931275

Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells.

J Segovia1, G M Lawless, N J Tillakaratne, M Brenner, A J Tobin.   

Abstract

C6 cells express proteins and mRNAs that are characteristic of both glia and neurons. Agents that increase intracellular levels of cyclic AMP (cAMP) decrease the enzymatic activity of glutamate decarboxylase (GAD), a neuronal marker, and the mRNA levels for one of the two GAD isoenzymes, GAD67. This reduction is accompanied by increased levels of glial fibrillary acidic protein (GFAP) mRNA, an astrocyte marker. Transient transfection assays, in which a 2-kb upstream regulatory region of the human GFAP gene was linked to a reporter gene, indicate that at least some of the cAMP-mediated increase of GFAP mRNA levels is due to increased transcription. Increases in intracellular cAMP appear to induce differentiation of C6 cells toward a more mature astrocyte phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931275     DOI: 10.1046/j.1471-4159.1994.63041218.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

1.  Astroglial differentiation of cortical precursor cells triggered by activation of the cAMP-dependent signaling pathway.

Authors:  M F McManus; L C Chen; I Vallejo; M Vallejo
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

2.  Different constitutive heat shock protein 70 expression during proliferation and differentiation of rat C6 glioma cells.

Authors:  K Helmbrecht; L Rensing
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

3.  Differential expression of small heat shock proteins in reactive astrocytes after focal ischemia: possible role of beta-adrenergic receptor.

Authors:  T Imura; S Shimohama; M Sato; H Nishikawa; K Madono; A Akaike; J Kimura
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

4.  Intraoperative delineation of primary brain tumors using time-resolved fluorescence spectroscopy.

Authors:  Pramod V Butte; Qiyin Fang; Javier A Jo; William H Yong; Brian K Pikul; Keith L Black; Laura Marcu
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

5.  Differentiating embryonic neural progenitor cells induce blood-brain barrier properties.

Authors:  Christian Weidenfeller; Clive N Svendsen; Eric V Shusta
Journal:  J Neurochem       Date:  2007-01-24       Impact factor: 5.372

6.  Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington's disease delays the onset of the motor phenotype.

Authors:  Leticia Arregui; Jorge A Benítez; Luis F Razgado; Paula Vergara; Jose Segovia
Journal:  Cell Mol Neurobiol       Date:  2011-06-17       Impact factor: 5.046

7.  Structure and alternative promoters of the mouse glutamic acid decarboxylase 67 gene.

Authors:  Y Yanagawa; T Kobayashi; T Kamei; K Ishii; M Nishijima; A Takaku; S Tamura
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

8.  5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells.

Authors:  Robert Meller; Joseph M Babity; David G Grahame-Smith
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

9.  Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat c6 glioma cells through production of 5alpha-reduced neurosteroids.

Authors:  Kyoji Morita; Song Her
Journal:  J Mol Neurosci       Date:  2008-01-25       Impact factor: 3.444

10.  Crosstalk between normal and tumoral brain cells. Effect on sex steroid metabolism.

Authors:  R C Melcangi; I Cavarretta; V Magnaghi; M Ballabio; L Martini; M Motta
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.